Furthermore, increased levels of circulating adipsin were closely associated with polycystic ovary syndrome (16), mild cognitive impairment in type 2 diabetic mellitus patients (18), and coronary artery disease (17), suggesting adipsin as a promising biomarker for the diseases. This evidence concerns the gene CFD and coronary artery disorder.